GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory infections, paying €400 million ($429 million) upfront for global rights to its influenza and COVID ...
GSK has shifted towards a global marketing model ... local teams are expected to use global content for a majority of their needs, leaving a small opportunity to originate local content for ...
(Alliance News) - GSK PLC on Friday said a trial of two ovarian cancer treatments met its primary endpoint but did not meet a key secondary target. Read More ...
As on 30-06-2024, the company has a total of 16.94 Crore shares outstanding.GSK Pharma Share Price Today is Rs. 2274.45 as on 27 Dec, 2024, 03:59 PM IST. On previous day, the GSK Pharma Share Price ...